Novavax (NVAX) Misses Q2 EPS by $12.03, Cuts FY Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $8.10 +0.62%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($6.53), $12.03 worse than the analyst estimate of $5.50. Revenue for the quarter came in at $186 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Novavax sees FY2022 revenue of $2-2.3 billion, versus the consensus of $4.27 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
